Home6HN • FRA
add
Everest Medicines Ltd
Previous close
€5.25
Day range
€5.35 - €5.35
Year range
€2.00 - €7.65
Market cap
15.76B HKD
Avg Volume
7.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 202.58M | 246.18% |
Operating expense | 203.13M | -11.35% |
Net income | -204.48M | 2.82% |
Net profit margin | -100.94 | 71.93% |
Earnings per share | — | — |
EBITDA | -26.69M | 84.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.60B | -31.77% |
Total assets | 4.96B | -14.10% |
Total liabilities | 886.05M | 10.19% |
Total equity | 4.07B | — |
Shares outstanding | 324.35M | — |
Price to book | 0.42 | — |
Return on assets | -2.73% | — |
Return on capital | -2.92% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -204.48M | 2.82% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2017
Website
Employees
665
